These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33252494)

  • 1. Effects of anticholinergic medication use on brain integrity in persons living with HIV and persons without HIV.
    Cooley SA; Paul RH; Strain JF; Boerwinkle A; Kilgore C; Ances BM
    AIDS; 2021 Mar; 35(3):381-391. PubMed ID: 33252494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinergic medication burden and cognitive function in participants of the ASPREE study.
    Broder JC; Ryan J; Shah RC; Lockery JE; Orchard SG; Gilmartin-Thomas JF; Fravel MA; Owen AJ; Woods RL; Wolfe R; Storey E; Murray AM; Ernst ME
    Pharmacotherapy; 2022 Feb; 42(2):134-144. PubMed ID: 34866212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiorespiratory Fitness Is Associated With Better White Matter Integrity in Persons Living With HIV.
    Kilgore CB; Strain JF; Nelson B; Cooley SA; Rosenow A; Glans M; Cade WT; Reeds DN; Paul RH; Ances BM
    J Acquir Immune Defic Syndr; 2022 Apr; 89(5):558-565. PubMed ID: 34966145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of comorbidity burden and age on brain integrity in HIV.
    Saloner R; Heaton RK; Campbell LM; Chen A; Franklin D; Ellis RJ; Collier AC; Marra C; Clifford DB; Gelman B; Sacktor N; Morgello S; McCutchan JA; Letendre S; Grant I; Fennema-Notestine C;
    AIDS; 2019 Jun; 33(7):1175-1185. PubMed ID: 30870195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
    Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK
    J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No Evidence for Accelerated Aging-Related Brain Pathology in Treated Human Immunodeficiency Virus: Longitudinal Neuroimaging Results From the Comorbidity in Relation to AIDS (COBRA) Project.
    Cole JH; Caan MWA; Underwood J; De Francesco D; van Zoest RA; Wit FWNM; Mutsaerts HJMM; Leech R; Geurtsen GJ; Portegies P; Majoie CBLM; Schim van der Loeff MF; Sabin CA; Reiss P; Winston A; Sharp DJ;
    Clin Infect Dis; 2018 Jun; 66(12):1899-1909. PubMed ID: 29309532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered neuropsychological performance and reduced brain volumetrics in people living with HIV on integrase strand transfer inhibitors.
    O'Halloran JA; Cooley SA; Strain JF; Boerwinkle A; Paul R; Presti RM; Ances BM
    AIDS; 2019 Jul; 33(9):1477-1483. PubMed ID: 31008801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia.
    Joshi YB; Thomas ML; Braff DL; Green MF; Gur RC; Gur RE; Nuechterlein KH; Stone WS; Greenwood TA; Lazzeroni LC; MacDonald LR; Molina JL; Nungaray JA; Radant AD; Silverman JM; Sprock J; Sugar CA; Tsuang DW; Tsuang MT; Turetsky BI; Swerdlow NR; Light GA
    Am J Psychiatry; 2021 Sep; 178(9):838-847. PubMed ID: 33985348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
    Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
    Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes.
    Hsu WH; Wen YW; Chen LK; Hsiao FY
    Ann Fam Med; 2017 Nov; 15(6):561-569. PubMed ID: 29133497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent effects of HIV, aging, and HAART on brain volumetric measures.
    Ances BM; Ortega M; Vaida F; Heaps J; Paul R
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):469-77. PubMed ID: 22269799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergic and sedative medication use in older patients with cognitive concerns.
    Hinkle CE; Davis JD; Arias I; Goldstein A; Daiello L; Margolis SA
    J Am Geriatr Soc; 2024 Sep; 72(9):2792-2799. PubMed ID: 38685717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Learning Analysis of Cerebral Blood Flow to Identify Cognitive Impairment and Frailty in Persons Living With HIV.
    Luckett P; Paul RH; Navid J; Cooley SA; Wisch JK; Boerwinkle AH; Tomov D; Ances BM
    J Acquir Immune Defic Syndr; 2019 Dec; 82(5):496-502. PubMed ID: 31714429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of anticholinergic burden in primary care patients with first cognitive complaints.
    Grande G; Tramacere I; Vetrano DL; Clerici F; Pomati S; Mariani C; Filippini G;
    Eur J Neurol; 2017 Jul; 24(7):950-955. PubMed ID: 28503836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.
    Risacher SL; McDonald BC; Tallman EF; West JD; Farlow MR; Unverzagt FW; Gao S; Boustani M; Crane PK; Petersen RC; Jack CR; Jagust WJ; Aisen PS; Weiner MW; Saykin AJ;
    JAMA Neurol; 2016 Jun; 73(6):721-32. PubMed ID: 27088965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
    Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
    J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinergic burden and cognitive performance: cross-sectional results from the ELSA-Brasil study.
    Dos Santos ANM; Junior GAAG; Benseñor IM; Goulart AC; Brunoni AR; Viana MC; Lotufo PA; Suemoto CK
    Eur J Clin Pharmacol; 2022 Sep; 78(9):1527-1534. PubMed ID: 35764818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse association between the anticholinergic burden and hippocampus volume in a population-based cohort across the entire adult age range.
    Kilimann I; Wucherer D; Ittermann T; Völzke H; Bülow R; Hoffmann W; Grabe HJ; Wittfeld K; Teipel SJ
    Geroscience; 2022 Jun; 44(3):1715-1726. PubMed ID: 34940948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prefrontal Cortex Volume Mediates the Relationship Between Lifetime Chronic Stressor Exposure and Cognition in People Living With and Without HIV.
    McIntosh EC; Beam C; Spahr CM; Slavich GM; Thames AD
    Psychosom Med; 2022 Oct; 84(8):904-913. PubMed ID: 35980777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impact of anticholinergic and sedative burden in people with HIV.
    Michael HU; Brouillette MJ; Tamblyn R; Fellows LK; Mayo NE
    AIDS; 2024 Nov; 38(13):1819-1828. PubMed ID: 38905493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.